As we age, stem cells throughout our bodies gradually lose their capacity to repair damage even from normal wear and tear. Researchers have discovered the reason why this decline occurs in our skeletal muscle.
You are here
Coverage of the latest news and updates from the field of stem cells and regenerative medicine.
What if repairing large segments of damaged muscle tissue was as simple as mobilizing the body’s stem cells to the site of the injury? New research suggests that “in body” regeneration of muscle tissue might be possible by harnessing the body’s natural healing powers.
The Food and Drug Administration (FDA) has given approval to begin a clinical trial of a stem cell therapy in patients with spinal cord injury. The phase I/IIa clinical trial is designed to test the safety of AST-OPC1 cells, a product of Asterias Biotherapeutics Inc., Menlo Park, Calif.
Rare stem cells in testes that produce a biomarker protein called PAX7 help give rise to new sperm cells—and may hold a key to restoring fertility.
Researchers at the University of Basel report that initial results of a clinical trial testing cartilage grafts for knees engineered from the patient’s nasal cells is “highly promising.”
Creating induced pluripotent stem cells (iPS cells) allows researchers to establish “disease in a dish” models of conditions ranging from Alzheimer’s disease to diabetes.
Gamida Cell has signed an investment and option agreement with Novartis in which the Swiss pharmaceutical company will receive 15% equity and an option to fully acquire Gamida Cell.
The U.S. Food and Drug Administration has accepted ViaCyte Inc.’s Investigational New Drug Application (IND) for its VC-01 candidate cell replacement therapy to treat type 1 diabetes.
A Roman Catholic diocese in Cincinnati is discouraging its 113 schools from participating in the Ice Bucket Challenge to benefit the ALS Association, saying the group's funding of embryonic stem cell research is "in direct conflict with Catholic teaching."
Stem cell biologists have found a way to reprogram a patient’s skin cells into cells that mimic and display many biological features of a rare genetic disorder called familial dysautonomia.